These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Should creatine kinase be checked in all boys presenting with speech delay? Lundy CT; Doherty GM; Hicks EM Arch Dis Child; 2007 Jul; 92(7):647-9. PubMed ID: 17588982 [No Abstract] [Full Text] [Related]
4. Muscular dystrophy: Are we looking for subtle signs? Biswas A Arch Dis Child; 2018 May; 103(5):522. PubMed ID: 29222177 [No Abstract] [Full Text] [Related]
5. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice. Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799 [TBL] [Abstract][Full Text] [Related]
12. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community. Verma S; Anziska Y; Cracco J Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320 [No Abstract] [Full Text] [Related]
13. EMA reconsiders 'read-through' drug against Duchenne muscular dystrophy following appeal. Mullard A Nat Biotechnol; 2014 Aug; 32(8):706. PubMed ID: 25101726 [No Abstract] [Full Text] [Related]
14. [Duchenne muscular dystrophy born prematurely showed normal CK value until 35 weeks of gestation age]. Morisawa T; Yagi M; Yoshii K; Takeshima Y; Matsuo M No To Hattatsu; 2004 Jul; 36(4):342-3. PubMed ID: 15272621 [No Abstract] [Full Text] [Related]
15. 50 years ago in the Journal of Pediatrics: the use of serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy. Proud CM J Pediatr; 2013 Dec; 163(6):1656. PubMed ID: 24274203 [No Abstract] [Full Text] [Related]
16. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function. Sato Y; Yamauchi A; Urano M; Kondo E; Saito K Pediatr Neurol; 2014 Jan; 50(1):31-7. PubMed ID: 24138948 [TBL] [Abstract][Full Text] [Related]
17. Year in review 2019: Neuromuscular diseases. Birnkrant DJ; Black JB Pediatr Pulmonol; 2020 Oct; 55(10):2542-2546. PubMed ID: 32691988 [TBL] [Abstract][Full Text] [Related]
18. 50 Years Ago in The Journal of Pediatrics: An Assessment of the Creatine Kinase Test in the Detection of Carriers of Duchenne Muscular Dystrophy. Cardon MW J Pediatr; 2017 Jul; 186():63. PubMed ID: 28648283 [No Abstract] [Full Text] [Related]
19. European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene. Haas M; Vlcek V; Balabanov P; Salmonson T; Bakchine S; Markey G; Weise M; Schlosser-Weber G; Brohmann H; Yerro CP; Mendizabal MR; Stoyanova-Beninska V; Hillege HL Neuromuscul Disord; 2015 Jan; 25(1):5-13. PubMed ID: 25497400 [No Abstract] [Full Text] [Related]
20. Duchenne drug clings on for FDA nod. Nat Biotechnol; 2017 Nov; 35(11):999. PubMed ID: 29121019 [No Abstract] [Full Text] [Related] [Next] [New Search]